Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cholesterol drug
Pharma
Amgen doesn't think Repatha's sales wins will stop anytime soon
With Repatha and several other key growth drivers, Amgen has outpaced declines from biosimilar competition to key brands in Q2.
Fraiser Kansteiner
Aug 4, 2026 4:01pm
Merck charts long-term path for first PCSK9 pill
Aug 4, 2026 2:38pm
Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth
Jul 21, 2026 10:36am
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
Jul 16, 2026 9:30am
ADA: Amgen talks Repatha, GLP-1 hurdles as obesity plan advances
Jun 7, 2026 9:13pm
Esperion to go private in potential $1.1B buyout by ArchiMed
May 1, 2026 11:26am
